Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 29, 2021ScienceOpen Access

Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine–elicited human sera

View Full Paper
Ask AI
Bookmark
Share

Authors

AMAlexander MuikBioNTech (Germany)AWAnn-Kathrin WallischBioNTech (Germany)BSBianca SängerInstitut zur Förderung von Bildung und Integration

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Muik et al. (2021) studied this question.

synapsesocial.com/papers/6a028cb4daa0ebdf9f9e21fahttps://doi.org/10.1126/science.abg6105
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Neutralization of N501Y mutant SARS-CoV-2 by BNT162b2 vaccine-elicited sera2021 · 161 citations
  2. 2Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy2020 · 851 citations
  3. 3A Vesicular Stomatitis Virus Replicon-Based Bioassay for the Rapid and Sensitive Determination of Multi-Species Type I Interferon2011 · 309 citations
  4. 4Mapping the Antigenic and Genetic Evolution of Influenza Virus2004 · 2,002 citations
  5. 5Hemagglutination Inhibition Antibody Titers as a Correlate of Protection for Inactivated Influenza Vaccines in Children2011 · 344 citations